NeuroPace to Present at the Leerink Partners Global Healthcare Conference
NeuroPace (Nasdaq: NPCE), a medical device company specializing in epilepsy treatment solutions, has announced its participation in the upcoming Leerink Partners 2025 Global Healthcare Conference in Miami, FL.
The company's management team is scheduled to present on Monday, January 10, 2025, at 4:20pm ET (1:20pm PT). In addition to the presentation, the management will be conducting investor meetings throughout the conference.
Interested parties can access the presentation through a live webcast, with a replay available for two weeks following the event on the Events section of NeuroPace's Investor website at investors.neuropace.com.
NeuroPace (Nasdaq: NPCE), un'azienda di dispositivi medici specializzata in soluzioni per il trattamento dell'epilessia, ha annunciato la sua partecipazione alla prossima Conferenza Globale sulla Salute 2025 di Leerink Partners a Miami, FL.
Il team di gestione dell'azienda è programmato per presentare lunedì 10 gennaio 2025, alle 16:20 ET (13:20 PT). Oltre alla presentazione, la direzione condurrà incontri con gli investitori durante tutta la conferenza.
Le parti interessate possono accedere alla presentazione tramite un webcast dal vivo, con una registrazione disponibile per due settimane dopo l'evento nella sezione Eventi del sito web per investitori di NeuroPace all'indirizzo investors.neuropace.com.
NeuroPace (Nasdaq: NPCE), una empresa de dispositivos médicos especializada en soluciones para el tratamiento de la epilepsia, ha anunciado su participación en la próxima Conferencia Global de Salud 2025 de Leerink Partners en Miami, FL.
El equipo directivo de la empresa está programado para presentar el lunes 10 de enero de 2025, a las 4:20 p.m. ET (1:20 p.m. PT). Además de la presentación, la dirección llevará a cabo reuniones con inversores durante toda la conferencia.
Las partes interesadas pueden acceder a la presentación a través de una transmisión en vivo, con una repetición disponible durante dos semanas después del evento en la sección de Eventos del sitio web para inversores de NeuroPace en investors.neuropace.com.
NeuroPace (Nasdaq: NPCE), 간질 치료 솔루션을 전문으로 하는 의료 기기 회사가 플로리다주 마이애미에서 열리는 Leerink Partners 2025 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다.
회사의 경영진은 2025년 1월 10일 월요일 오후 4시 20분 ET (오후 1시 20분 PT)에 발표할 예정입니다. 발표 외에도 경영진은 컨퍼런스 기간 동안 투자자 회의를 진행할 것입니다.
관심 있는 분들은 NeuroPace의 투자자 웹사이트인 investors.neuropace.com의 이벤트 섹션에서 이벤트 후 2주 동안 재생 가능한 생중계로 발표를 접할 수 있습니다.
NeuroPace (Nasdaq: NPCE), une entreprise de dispositifs médicaux spécialisée dans les solutions de traitement de l'épilepsie, a annoncé sa participation à la prochaine Conférence Mondiale sur la Santé 2025 de Leerink Partners à Miami, FL.
L'équipe de direction de l'entreprise est prévue pour présenter le lundi 10 janvier 2025, à 16h20 ET (13h20 PT). En plus de la présentation, la direction tiendra des réunions avec les investisseurs tout au long de la conférence.
Les parties intéressées peuvent accéder à la présentation via un webinaire en direct, avec une rediffusion disponible pendant deux semaines après l'événement dans la section Événements du site Web des investisseurs de NeuroPace à l'adresse investors.neuropace.com.
NeuroPace (Nasdaq: NPCE), ein Unternehmen für medizinische Geräte, das sich auf Lösungen zur Behandlung von Epilepsie spezialisiert hat, hat seine Teilnahme an der bevorstehenden Leerink Partners 2025 Global Healthcare Conference in Miami, FL, angekündigt.
Das Management-Team des Unternehmens wird am Montag, den 10. Januar 2025, um 16:20 Uhr ET (13:20 Uhr PT) präsentieren. Neben der Präsentation wird das Management während der gesamten Konferenz Investorenmeetings durchführen.
Interessierte Parteien können die Präsentation über einen Live-Webcast abrufen, wobei eine Wiederholung zwei Wochen nach der Veranstaltung im Bereich Veranstaltungen der Investorenseite von NeuroPace unter investors.neuropace.com verfügbar ist.
- None.
- None.
MOUNTAIN VIEW, Calif. , March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerink Partners 2025 Global Healthcare Conference at 4:20pm ET (1:20pm PT) on Monday, January 10, 2025, in Miami, FL. Management will also host investor meetings during the conference.
The presentation will be accessible via live webcast here. A webcast replay will be available for two weeks following the presentation in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When is NeuroPace (NPCE) presenting at the Leerink Partners Global Healthcare Conference 2025?
How can investors watch NeuroPace's (NPCE) presentation at the Leerink Conference?
Will NeuroPace (NPCE) management be available for investor meetings at the Leerink Conference?
How long will the replay of NeuroPace's (NPCE) Leerink Conference presentation be available?
